“To Compare Effectiveness and Safety of Teneligliptin vs Glimepiride in Patients with Type 2 Diabetes Mellitus”, AJM, vol. 4, no. 2, pp. 39–43, Nov. 2021, doi: 10.48165/h2ktab59.